Citations

Showing 10 of 108104 citations.

Accuracy of Point‐of‐Care Blood Glucose Level Measurements in Critically Ill Patients with Sepsis Receiving High‐Dose Intravenous Vitamin C
Smith, Kathryn , Brown, Caitlin S. , Manning, Bridget M., May, Teresa , Riker, Richard R. , Lerwick, Patricia , Hayes, Timothy L., Smith, Kathryn E , Hayes, Timothy L., Fraser, Gilles L.

Mayo Clinic

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy | September 19, 2018 | Volume: 38 | Issue: 11 | Pages: 1155-1161

10.1002/phar.2182 | PMID 30230568 Get It

Study ObjectiveHigh‐dose intravenous vitamin C is a potential treatment option for patients with sepsis and may interfere with point‐of‐care (POC) blood glucose (BG) testing. This study aimed to determine if vitamin C dosing used for sepsis affected POC BG level results.DesignProspective observational pilot study.SettingIntensive care unit in a large academic tertiary care medical center.PatientsFive consecutive critically ill adults hospitalized between April 1 and June 1, 2017, who received two or more doses of intravenous vitamin C 1500 mg for the treatment of sepsis and had at least two paired POC BG levels and laboratory venous BG levels measured within 1 hour of each other during vitamin C therapy.Measurements and Main ResultsThe performance of POC BG level measurement was compared with the reference method of laboratory BG level measurement. The concordance to minimum accuracy criteria for BG meters set forth by the International Organization for Standardization (ISO) 15197:2013, the measurement of agreement between POC BG level and laboratory BG level using the Bland‐Altman method, and the clinical accuracy through Parkes error grid analysis were assessed. A total of 16 paired POC and laboratory BG level measurements from the five patients were included. The accuracy of POC BG with laboratory BG level measurements during vitamin C administration according to ISO 15197:2013 criteria was 81.3%, which did not meet the minimum accuracy criteria of 95%. The Bland‐Altman analysis showed a mean difference between POC and laboratory BG levels of 8.9 mg/dl, and the Parkes error grid analysis showed that the differences between POC and laboratory BG level measurements would not have resulted in a change in clinical action.ConclusionThe accuracy and agreement of POC and laboratory BG level measurements in critically ill patients receiving vitamin C were consistent with previously published reports in critically ill patients not receiving vitamin C and did not demonstrate clinically significant interference due to vitamin C dosing for sepsis.
P05.83 Tumor Treating Fields and radiosurgery for supra- and/or infratentorial brain metastases (1–10) from NSCLC in the phase 3 METIS study
Bähr, Oliver , Gondi, Vinai , Ahluwalia, Manmeet S. , Brown, Paul D. , Ahluwalia, Manmeet S , Mehta, Minesh P.

Mayo Clinic

Neuro-Oncology | September 19, 2018 | Volume: 20 | Issue: suppl_3 | Pages: iii322-iii323

10.1093/neuonc/noy139.409 Get It

P01.001 Bevacizumab use in adult pilocytic astrocytoma, a single center experience
Ruff, Michael W. , Carabenciov, D, Uhm, Jieun , Carabenciov, Darin D., Uhm, J

Mayo Clinic

Neuro-Oncology | September 19, 2018 | Volume: 20 | Issue: suppl_3 | Pages: iii227-iii228

10.1093/neuonc/noy139.043 Get It

Clinical Phenomenology and Characteristics of Centenarians in Hospice
Schoonover, Kimberly , Schoonover, Kimberly L, Lapid, Maria I.

Mayo Clinic

Journal of Palliative Care | September 19, 2018 | Volume: 34 | Issue: 1 | Pages: 47-51

10.1177/0825859718800491 | PMID 30229699 Get It

Objectives: Little is known about the hospice experience of centenarians. As the population of centenarians is projected to increase, understanding their unique end-of-life needs will be important to inform delivery of quality end-of-life care. Our objective was to characterize the hospice experience of centenarians. Methods: A retrospective single-institution cohort study of centenarians enrolled in hospice from January 1, 2015, to December 31, 2017, was conducted to collect demographic and clinical information. Results: Seventeen centenarians, who comprised 1.4% of hospice admissions, had an average age of 102 years, were mostly female (71%) and widowed (76%), and all caucasian. Upon hospice admission, centenarians resided in nursing (8, 47%) and assisted living (4, 24%) residencies as well as at home (4, 24%) and in senior independent living (1, 6%). Sixty percent of centenarians died in a nursing home. The most common hospice admission diagnosis was dementia (35%). Median length of stay on hospice was 41 days (range: 16-85) for 15 persons who died or discharged live. Conclusions: In this group of centenarians, dementia was the most common condition for hospice enrollment. Slightly less than half resided in nursing homes on admission, although death occurred most frequently in a nursing home. Centenarians were generally able to remain out of the hospital at their time of death.
I Don’t Know
Hilal, Talal , Hilal, Talal

Mayo Clinic

American Journal of Hospice and Palliative Medicine® | September 19, 2018 | Volume: 36 | Issue: 4 | Pages: 348-349

10.1177/1049909118800278 | PMID 30227730 Get It

Withholding Perioperative Steroids in Patients Undergoing Transsphenoidal Resection for Pituitary Disease: Randomized Prospective Clinical Trial to Assess Safety
Sterl, Karin, Thompson, Bithika , Goss, Charles W. , Dacey, Ralph G. , Rich, Keith M. , Zipfel, Gregory J. , Silverstein, Julie , Chicoine, Michael , Kim, Albert H.

Mayo Clinic

Neurosurgery | September 19, 2018 | Volume: 85 | Issue: 2 | Pages: E226-E232

10.1093/neuros/nyy479 | PMID 30325449 Get It

Abstract BACKGROUND Perioperative steroid protocols for patients undergoing transsphenoidal surgery (TSS) for pituitary pathology vary by institution. OBJECTIVE To assess the safety of withholding glucocorticoids in patients undergoing TSS. METHODS Patients with an intact hypothalamic-pituitary-adrenal (HPA) axis undergoing TSS for a pituitary tumor at the same academic institution between 2012 and 2015 were randomized to either receive 100 mg of intravenous hydrocortisone followed by 0.5 mg of intravenous dexamethasone every 6 h for 4 doses (STER, n = 23) or to undergo surgery without steroids (NOSTER, n = 20). Postoperative cortisol levels were then used to determine the need for glucocorticoids after surgery. Data regarding postoperative cortisol levels, hospital stay length, and complications were collected. RESULTS Mean postoperative 8 am cortisol levels were higher in the NOSTER group compared to the STER group (745 ± 359 nmol/L and 386 ± 193 nmol/L, respectively, P = .001) and more patients were discharged on glucocorticoids in the STER group (42% vs 12%, P = .07). There was no difference in the incidence of postoperative complications, including hyperglycemia, diabetes insipidus, or permanent adrenal insufficiency. Permanent adrenal insufficiency occurred in 8% of patients. CONCLUSION Perioperative steroids can be safely withheld in patients with an intact HPA axis undergoing TSS. Although administration of perioperative glucocorticoids does not appear to increase the risk of complications, it may interfere with assessment of the HPA axis after surgery.
Scapholunate Ligament Internal Brace 360 Tenodesis (SLITT) Procedure: A Biomechanical Study
Greene, Ryan M. , Denbeigh, Janet M. , Wijnen, André J. van , Denbeigh, Janet, van Wijnen, Andre, van Wijnen, Andre J , Kakar, Sanjeev

Mayo Clinic

Journal of Wrist Surgery | September 18, 2018 | Volume: 08 | Issue: 03 | Pages: 250-254

10.1055/s-0038-1670682 | PMID 31192049 Get It

Background Twelve paired fresh frozen cadaveric wrists were randomized to a 360-degree tenodesis repair group or the 360-degree tenodesis repair with an internal brace (suture tape) construct. Case Description The specimens were preloaded to 5 N and subsequently biomechanically loaded to failure, at a rate of 0.1 mm/s on a jig that allowed for axial load. The maximum load and mode of failure were recorded. Load to failure in the 360 tenodesis group with internal brace was 283.47 ± 100.25 N, compared with the 360 tenodesis group only, whose yield strength was 143.61 ± 90.54 N. The mode of failure within the internal brace construct was either through knot slippage, graft disruption, or bone separation from strength testing construct. The 360 tenodesis group tended to fail via graft slippage or graft rupture. Literature Review The management of scapholunate instability can be a difficult problem to treat. Traditionally, many of the surgical reconstructions have focused upon dorsal ligament reconstruction with Kirschner (K) wire fixation. This results in prolonged immobilization of the wrist with varied outcomes, in part due to the multiaxial instability that may persist due to concomitant volar ligament disruption. To address this instability, surgical techniques have been devised that address both the volar and dorsal ligament injuries. Clinical Relevance Scapholunate reconstruction with a 360-degree tenodesis and internal brace augmentation (SLITT procedure) provided superior biomechanical stability than tenodesis alone.
Rapid Molecular Diagnostics to Inform Empiric Use of Ceftazidime/Avibactam and Ceftolozane/Tazobactam Against Pseudomonas aeruginosa: PRIMERS IV
Tran, Thuy Tien T., Hujer, Andrea M. , Hill, Carol , Hujer, Kristine M., Mediavilla, José R. , Pérez, Federico , Farmer, Michael , Pitzer, Kelsey, Wilson, Brigid , Kreiswirth, Barry N. , Patel, Robin , Chen, Liang , Fowler, Vance G. , Chambers, Henry F. , Chen, Liang , Patel, Robin , Evans, Scott R , Evans, Scott , Manca, Claudia , Domitrovic, Tatiana , Farmer, Michael, Kreiswirth, Barry N , Jacobs, Michael R. , Fowler, Vance G. , Bonomo, Robert A.

Mayo Clinic

Clinical Infectious Diseases | September 18, 2018 | Volume: 68 | Issue: 11 | Pages: 1823-1830

10.1093/cid/ciy801 | PMID 30239599 Get It

AbstractBackgroundOvercoming β-lactam resistance in pathogens such as Pseudomonas aeruginosa is a major clinical challenge. Rapid molecular diagnostics (RMDs) have the potential to inform selection of empiric therapy in patients infected by P. aeruginosa.MethodsIn this study, we used a heterogeneous collection of 197 P. aeruginosa that included multidrug-resistant isolates to determine whether 2 representative RMDs (Acuitas Resistome test and VERIGENE gram-negative blood culture test) could identify susceptibility to 2 newer β-lactam/β-lactamase inhibitor (BL-BLI) combinations, ceftazidime/avibactam (CZA) and ceftolozane/tazobactam (TOL/TAZO).ResultsWe found that the studied RMD platforms were able to correctly identify BL-BLI susceptibility (susceptibility sensitivity, 100%; 95% confidence interval [CI], 97%, 100%) for both BLs-BLIs. However, their ability to detect resistance to these BLs-BLIs was lower (resistance sensitivity, 66%; 95% CI, 52%, 78% for TOL/TAZO and 33%; 95% CI, 20%, 49% for CZA).ConclusionsThe diagnostic platforms studied showed the most potential in scenarios where a resistance gene was detected or in scenarios where a resistance gene was not detected and the prevalence of resistance to TOL/TAZO or CZA is known to be low. Clinicians need to be mindful of the benefits and risks that result from empiric treatment decisions that are based on resistance gene detection in P. aeruginosa, acknowledging that such decisions are impacted by the prevalence of resistance, which varies temporally and geographically.
Age-Dependent Decrease of Mitochondrial Complex II Activity in a Familial Mouse Model for Alzheimer’s Disease
Emmerzaal, Tim L. , Tanila, Heikki , Verweij, Viviènne, Rodenburg, Richard , Kiliaan, Amanda J. , Kozicz, Tamás

Mayo Clinic

Journal of Alzheimer’s Disease | September 18, 2018 | Volume: 66 | Issue: 1 | Pages: 75-82

10.3233/jad-180337 | PMID 30248054 Get It

Alzheimer’s disease (AD) is a severe neurodegenerative disorder for which the exact etiology is largely unknown. An increasingly recognized and investigated notion is the pathogenic role of mitochondrial dysfunction in AD. We assessed mitochondrial oxidative-phosphorylation (OXPHOS) enzyme activities in the APPswe/PS1ΔE9 mouse model from 4.5 to 14 months of age. We show an age-dependent decrease in mitochondrial complex-II activity starting at 9 months in APP/PS1 mice. Other enzymes of the OXPHOS do not show any alterations. Since amyloid-β (Aβ) plaques are already present from 4 months of age, mitochondrial dysfunction likely occurs downstream of Aβ pathology in this mouse model.